ClinicalTrials.gg
Not yet recruitingNCT07908056Updated Oct 30, 2026

Evaluate Precision of the Test for Lactate in Capillary Whole Blood Specimens Using the i-STAT CG4+ Cartridge With the i-STAT 1 Analyzer

An observational study in Lactate, sponsored by Abbott Point of Care. Not yet recruiting at 3 sites in United States. Open to participants aged 18 Years and older, including healthy volunteers. Per ClinicalTrials.gov, last updated 2026-10-30.

Sponsored by Abbott Point of Care (part of Abbott) · Observational

Updated Oct 30, 2026Newly registeredGo to Updates ↓

Help build ClinicalTrials.gg — short surveys, remote interviews or testing, in your language. Take part →

Study type
Observational
Model
Cohort
Time perspective
Prospective
Enrollment
425
Ages
18 Years and older
Sex
All
01

Study summary

Assess precision of the i-STAT lactate test with the i-STAT CG4+ cartridge on the i-STAT 1 analyzer using two (2) separate capillary blood specimens.

Read the detailed description

The objective of this study is to assess the precision of the i-STAT lactate test using i-STAT CG4+ cartridge on the i-STAT 1 analyzer with two (2) separate capillary specimens for each subject enrolled in the study.

02

Conditions studied

  • Lactate

Keywords

  • Lactate
03

In context

Lead sponsor

Abbott Point of Care is the lead sponsor of 9 studies on the registry; 1 is open to participants now.

First submitted after Abbott Point of Care became part of Abbott.

Counted across the registry records on this site, refreshed daily.

04

Who can participate

Ages eligible
18 Years and older
Sexes eligible
All
Accepts healthy volunteers
Yes
Sampling method
Non-probability sample

Study population

Subjects from the intended use population.

Go through the criteria one by one — yes, no or not sure — and take the list to your doctor or the study team. Kept in this browser only.

Inclusion criteria

Subject Inclusion Criteria

  1. Signed and dated consent form (waiver/alteration of consent, waiver of documentation of consent may be acceptable, per IRB)
  2. ≥ 18 years of age

Exclusion criteria

Exclusion Criteria:

Subject Exclusion Criteria

1. Previous enrollment in this study

05

Study design

Observational model
Cohort
Time perspective
Prospective
Enrollment
425 participants (estimated)
Target follow-up
1 Day
Patient registry
Yes

Groups and cohorts

  • Prospectively enrolled subjects

    Prospectively enrolled subjects in the intended use population.

    Diagnostic Test: Fingerstick capillary blood draw

Interventions

  • Diagnostic testFingerstick capillary blood draw

    Fingerstick capillary blood draw

06

What researchers measure

Primary outcomes

  1. Precision across the reportable range for lactate

    The primary outcome measure is to assess the precision across the lactate reportable range for the i-STAT lactate test using the i-STAT CG4+ cartridge on the i-STAT 1 analyzer.

    Time frame: Through study completion, an average of 1 year

07

Study locations

3 sites
08

References and documents

Individual participant data

Plan to share: No

No publications or documents are linked to this record.

09

Timeline

1 registry update since Sep 25, 2026
ElapsedEstimatedEstimated, not yet reached

Start is estimated for Oct 2026; primary completion for May 2027, 7 months later.

How these figures are worked out, and which studies are left out of them.

Registered
Oct 23, 2026
First posted
Oct 30, 2026
StartEst.
Oct 22, 2026
Primary completionEst.
May 31, 2027
CompletionEst.
Oct 30, 2027
Last update
Oct 30, 2026
What these dates mean
Start.
When the first participant enrolled; while estimated, when the study expects to open to recruitment.
Primary completion.
When the last participant was examined or treated to collect data for the study's main question, its primary outcome. A study that stopped early gives the date its data collection stopped.
Completion.
When the last participant's last visit took place, for every outcome, secondary ones and side effects included: the end of the study. Often later than primary completion, sometimes the same day.
Actual and Est.
Actual means the registry says the date has happened. Est. (estimated) is a date the sponsor plans or expects. It can still move, and the sponsor is expected to change it to actual once it has passed.
Registered
First appeared on the registry. No changes since
Oct 30, 2026
Show all 1 update
  1. Oct 30, 2026
    First appeared on the registry

From the registry record's own update history. This site started tracking changes on Sep 25, 2026; for anything earlier, see the record history on ClinicalTrials.gov ↗

10

Registry details

Key details

Study ID
NCT07908056
Responsible party
Sponsor
First posted
Oct 30, 2026
Start date
Oct 22, 2026 (estimated)
Primary completion
May 31, 2027 (estimated)
Completion
Oct 30, 2027 (estimated)
Last update
Oct 30, 2026

Study contacts

Miranda Gonzalez Aguirre, PhD
Contact
miranda.gonzalezaguirre@abbott.com
+ 1 613-604-8539
Manish Gupta, MS, MBA
study director · Abbott Point of Care

Oversight

Data monitoring committee
No
FDA-regulated drug
No
FDA-regulated device
Yes
View the source record on ClinicalTrials.gov ↗

Not currently enrolling

This study is not yet recruiting, as verified in Oct 2026. You cannot join it, but the record below documents what was studied.

Follow this study

Get an email when the registry record changes — status, dates, results — or when someone posts here.

Sign in to follow

Discussion

Questions and observations about this study, from anyone following it. Not medical advice, and not a channel to the study team — their contact details are on the registry record.

Sign in to join the discussion. Reading takes no account; posting does. You choose a display name, and a pseudonym is the default.

Nothing here yet. If you are running this trial, taking part in it, or weighing whether to, this is the place to say so.

Start the discussion